U
WGBS

UBS’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

UBS’s Portfolio WGBS Stock Details WGBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4K Buy
+202
New +$4.5K ﹤0.01% 9706

Other funds holding WGBS

AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS's WGBS Position: Q3 2014 in Review

UBS opened a new position in WaferGen Bio-systems, Inc. (WGBS) in Q3 2014: 202 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #9706 among its holdings.

13 funds tracked by Wall St. Rank hold WGBS as of Q3 2014.

  • UBS held 202 shares of WaferGen Bio-systems, Inc. worth $4K as of Q3 2014.
  • WaferGen Bio-systems, Inc. was a new UBS position in Q3 2014.
  • WaferGen Bio-systems, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9706 holding.
  • 13 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.